(PubMed) Ziegler D, Low PA, Freeman R, Tritschler H, Vinik AI
A 2024 case series in Journal of Clinical Endocrinology reported that patients receiving combination therapy showed 18% greater fat mass reduction compared to GLP-1 monotherapy, with improved energy scores on validated fatigue assessments (Morrison et al., 2024)
At the same time, the HOMO population decreases from around 1.82 e- during the optimization process until the Co-C bond is broken
However, not everyone converts synthetic forms efficiently, particularly those with higher metabolic stress, liver strain, or certain genetic variations including the MTHFR mutation
IGF-1 LR3 is a synthetic, modified version of the peptide